Literature DB >> 34243774

Familial SYN1 variants related neurodevelopmental disorders in Asian pediatric patients.

Juan Xiong1,2, Haolin Duan1,2, Shimeng Chen1,2, Miriam Kessi1,2, Fang He1,2, Xiaolu Deng1,2, Ciliu Zhang1,2, Li Yang1,2, Jing Peng1,2, Fei Yin3,4.   

Abstract

BACKGROUND: SYN1 encodes synapsin I, which is a neuronal phosphoprotein involving in regulating axonogenesis and synaptogenesis. Variants in the gene have been associated with X-linked neurodevelopmental disorders in recent years.
METHODS: In the study, we reported two male patients with familial SYN1 variants related neurodevelopmental disorders from Asian population. Previously published cases with significant SYN1 variants from the literature were also included to analyze the phenotype and genotype of the disorder.
RESULTS: Two maternally inherited SYN1 variants, including c.C1076A, p.T359K in proband A and c.C1444T, p. Q482X in proband B (NM_133499) were found, which have never been described in detail. Combining with our research, all reported probands were male in the condition, whose significant SYN1 variants were inherited from their asymptomatic or mild affected mother. Although the disorder encompasses three main clinical presentations: mental deficiency, easily controlled reflex seizure and behavior problems, patients' clinical manifestations vary in genders and individuals, even in the same pedigree.
CONCLUSION: We firstly reported two familial SYN1-related neurodevelopmental disorders in Asian pediatric patients. Gender and phenotype differences should be highly valued in the disorder.
© 2021. The Author(s).

Entities:  

Keywords:  Gender differences; Loss-of-function; Neurodevelopmental disorders; SYN1; Variants

Mesh:

Year:  2021        PMID: 34243774      PMCID: PMC8272254          DOI: 10.1186/s12920-021-01028-4

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


Background

SYN1(OMIM 313440) encodes Synapsin I protein, forming synaptic vesicles (SV) with other Synapsin subtypes including Synapsin II and Synapsin III, which has been confirmed to play crucial roles in synaptogenesis, synaptic neurotransmission, axonogenesis, and neuronal development in central and peripheral nervous system [1]. Homo sapiens Synapsin I protein has two isoforms, Ia (NP_008881, 705aa) and Ib (NP_598006, 669aa), both of which contain four former similar domains (A-D) and a distinctive C-terminus, with domain E in Synapsin Ia, domain F for Synapsin Ib [2]. Biallelic disruption of SYN1 gene in mice results in seizures, autism-related behavioral abnormalities [3]. Variants in SYN1 gene are related with X-linked epilepsy with variable learning disabilities and behavior disorders (OMIM 300491) and (or) X-linked intellectual disability (OMIM 300115) [4]. Like other X-linked neurodevelopmental disorders such as Turner-type X-linked syndromic mental retardation (OMIM 309590), the disease's clinical characteristics differ in gender. Most affected individuals are males, whose clinical presentations include variable degrees of intellectual disability/global developmental delay, epilepsy, movement disorder, autistic traits, and behavior problems. In contrast, female carriers are often asymptomatic or only exhibit mild cognitive impairment or febrile seizures [4]. All reported patients with SYN1 related neurodevelopmental disorders are from European and North American studies, but none from Asian population. In the study, we reported two maternally inherited SYN1 variants (c.C1076A, p.T359K and c.C1444T, p. Q482X) (NM_133499) detected in two male pediatric patients with neurodevelopmental disorder. The study was accompanied by a comprehensive literature review about the genotypes, phenotypes of the condition. To the best of our knowledge, this is the first report about SYN1-related neurodevelopmental disorders in Asian population.

Methods

Subjects

Proband A and B were firstly referred to the Pediatric Department at Xiangya Hospital, Central South University with complaining of intellectual disabilities. Written informed consents for genetic testing were obtained from their pedigrees. The study was approved by the institutional medical ethics committee of Xiangya hospital, Central South Univesity.

Molecular and bioinformatic analysis

Genomic DNAs were extracted from whole blood samples by using Phenol/chloroform method. The chromosomal karyotype and copy number variations of probands were detected by G-banding technique and chromosome microarray (CMA), separately. Trio whole-exome sequencing (Trio-WES) was performed on both pedigrees, and analyzed as described before [5]. Candidate variants were validated by Sanger sequencing. Variant impact predictor software including PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/), PROVEAN (http://provean.jcvi.org/), Mutation Taster (http://www.mutationtaster.org/), and the American College of Medical Genetics (ACMG) guidelines, was used to analyze the pathogenicity of the variants [6].

Literature review

Literature search on PubMed and Embase database in English was performed by combining “SYN1” or “Synapsin I” and “variants” or “mutations” until 24 April, 2021. Only those consumed significant SYN1 variants were included to further analyze the genotypes of the disorder. Patients or pedigrees with clinical information were enrolled for concluding clinical features of SYN1-related neurodevelopmental disorder.

Results

Clinical information

Proband A and pedigree A

The patient was a 6 years and 3 months old boy, who was born in a non-consanguineous family. Before the birth of this child, his mother had a history of induced abortion due to taking fungal drugs, and a history of unexplained spontaneous abortion. In addition, the mother had an early threatened miscarriage during the pregnancy of the case, but got remissions after immediate medical intervention. The proband was delivered at full-term via caesarian section. The physical examination was normal at birth. The most remarkable clinical symptom in proband A was profound global developmental delay since his infancy. His gross and fine motor skills were acquired and improved slowly: achieved neck muscle control at 15-month-old age, sat with support at 4-year-old age, walked dependently, but inflexible finger movements at the last evaluation. He also had great difficulties in language development. He only could make some responses to simple words or instructions, but had nonverbal expression at the last follow-up. His daily life needed to be fully taken care of by others. No behavior problem had been found in proband A until now. Two febrile convulsions were observed at his 1-year-old age and 2-year-old age. The electroencephalogram (EEG) and magnetic resonance imaging (MRI) of the brain at 4 years old age were normal. Meanwhile, the development quotients for adaptability, gross motor movements, fine motor movements, language, and individual–social interaction on the Gesell developmental scales were 36, 41, 30, 43, and 50, respectively. Other laboratory examinations, including the routine blood biochemical tests, metabolic analyses yielded negative. He had a medical history of bilateral esotropia. Proband A had a healthy younger brother whose age was two years old (Fig. 1a). His mother had no neurological signs. His biological father had self-limited febrile seizures at childhood. There was no other family history of neurological disorders to disclose.
Fig. 1

Two Asian patients with maternal inherited SYN1 variants. The above two figures (a, b) show the segregation of the SYN1 variants in the two pedigrees. a Pedigree A and b pedigree B: , female carrier; , affected male; arrow, the proband; , induced abortion; , spontaneous abortion. The middle two figures (c, d) show electropherograms of SYN1 genomic sequences of the two pedigrees. The represented DNA sequences is in positive strand. e The alignment of the SynI protein sequence across species. The mutated amino acids are marked in red color, and lay in conserved positions as indicated

Two Asian patients with maternal inherited SYN1 variants. The above two figures (a, b) show the segregation of the SYN1 variants in the two pedigrees. a Pedigree A and b pedigree B: , female carrier; , affected male; arrow, the proband; , induced abortion; , spontaneous abortion. The middle two figures (c, d) show electropherograms of SYN1 genomic sequences of the two pedigrees. The represented DNA sequences is in positive strand. e The alignment of the SynI protein sequence across species. The mutated amino acids are marked in red color, and lay in conserved positions as indicated

Proband B and pedigree B

An 8.5-year-old boy presenting with intellectual disability, epilepsy, abnormal social behavior, and ametropia came to our center's clinic. The patient was born as the third child of unrelated healthy parents after uneventful pregnancy and delivery. His distant uncle was diagnosed with intellectual disability, and an older female cousin had mood disorder. The case began to have yearly epileptic seizures at his 7-year-old age, which was characterized with sudden loss of consciousness, rigidity of the limbs, and lips cyanosis, lasting for minutes. His video EEG revealed occasional sharp-waves in the bilateral frontal areas during sleep, that was absent in wake-time. Brain MRI showed no obvious structural abnormalities. His seizure was well controlled on levetiracetam at the last-follow-up. He lagged behind the peers in intelligence development, with poor school performance and bad communication skills. The intelligence quotient score at his 8.5-year-old age was 50.9. He also exhibited uncontrolled tempers, social problems, attention deficit, and hyperactivity. Nevertheless, the behavior assessments, including Conners' Comprehensive Behavior Rating Scales (CBRS), Kiddie-SADS DSM-5 Screen Interview (K-SADS-PL), and Autism Behavior Checklist (ABC) were negative. Metabolic, immunological, and infectious etiology were excluded after the diagnostic workup. The proband had two healthy elder sisters, 18 and 14 years old. They both performed well in school (Fig. 1b). His low-level educated parents could work and support their family well.

Genetic findings

The analyses of karyotype and copy number variation in the two probands showed no abnormalities in their chromosomes. Maternal inherited SYN1 variants were identified by Trio-WES. In pedigree A, the missense variant c.C1076A, p.T359K in exon 9 of SYN1 gene (NM_133499) was present in a hemizygous state in proband A and a heterozygous state in his mother, grandmother, and great-grandmother as obligate carriers, but was absent in his younger brother, father, and grandfather (Fig. 1a, c). The variant T359K is recorded as a variant of uncertain significance in ClinVar database records (accession VCV000589101.2), associated with a "history of neurodevelopmental disorder" [7]. And 1 of 161,942 individuals in the gnomAD database showed hemizygous presence of variant T359K [8]. The substitution of lysine for threonine acid at position 359 within domain C of SYN1 protein is considered as "possibly damaging" (score 0.886) with PolyPhen2 (http://genetics.bwh.harvard.edu/pph2/), "deleterious" (score − 2.565) with PROVEAN (http://provean.jcvi.org/) and "disease-causing" (score 78) with MutationTaster (http://www.mutationtaster.org/). In pedigree B, the truncated variant c.C1444T, p.Q482X (NM_133499) in exon 12 of SYN1 was identified, which was present in a hemizygous state in the proband, and a heterozygous state in his mother, but was absent in his father (Fig. 1d). The variant validation of other family members was not done for financial reasons (Fig. 1b). The variant has never been reported before and could not be found in dbSNP143, gnomAD, and Clinvar database. The nonsense variant Q482X lies in the domain D of the protein, and is identified as "disease-causing" (score 6) with MutationTaster (http://www.mutationtaster.org/). Bioinformatic analysis showed that sites T359 and Q482 are highly conserved residues among different species (Fig. 1e). The variant T359K was classified as “Uncertain significance” (PM1 + PM2 + PP3), while the other variant was “Pathogenic” (PVS1 + PM2 + PP3), according to the ACMG guidelines [6].

Genotype and phenotype of SYN1-related neurodevelopmental disordrer

Since Garcia CC et al. firstly connected SYN1 variants with neurodevelopmental disorder in 2004, 16 causative variants including ten missense mutations, five nonsense mutations, and one splicing site mutation in the gene have been reported (containing this study) (Fig. 2) [1, 4, 9–18]. These variants are clustered in B linker domain (A51G, S79W), actin-binding and synaptic-vesicle binding C-domain (W126X, W126R, c.527 + 1G > A, S212I, G240R, V266M, W356X, T359K, R420G) and proline-rich D-domain (R422X, Q482X, A550T, Q555X, T567A) of synapsin I as indicated (Fig. 2).
Fig. 2

Synapsin I protein diagram and the distribution of the variants. The SYN1 gene encodes two isoforms, Ia and Ib. They have four former similar domains (A–D), and a distinctive C-terminus (domain E or F). The isoform of Synapsin Ia is longer and expressed higher than Synapsin Ib. The variants identified in previous studies and this study (marked as asterisk) are indicated with different colors denoting different mutation types, including 10 missense variants (in black color), 5 truncation variants (in red color), and 1 splicing variant (in blue color)

Synapsin I protein diagram and the distribution of the variants. The SYN1 gene encodes two isoforms, Ia and Ib. They have four former similar domains (A–D), and a distinctive C-terminus (domain E or F). The isoform of Synapsin Ia is longer and expressed higher than Synapsin Ib. The variants identified in previous studies and this study (marked as asterisk) are indicated with different colors denoting different mutation types, including 10 missense variants (in black color), 5 truncation variants (in red color), and 1 splicing variant (in blue color) Clinical information of 7 pedigrees in 7 reported studies and 2 pedigrees in our study was summarized in Table 1 [4, 11–16], after excluding those cases without detailed clinical descriptions [1, 9, 10, 17, 18]. 5/9 pedigrees had normal or mild cognitive impairments, 3/9 pedigrees had moderate to severe global developmental delay, while 1/9 pedigree showed mental regression (Table 1). Cases in 6/9 pedigrees were diagnosed with epilepsy, which could be triggered by bathing or showering [11, 15]. Most cases had mild seizure forms which responded well to antiepileptic drugs. Behavioral problems such as aggression, hyperactivity, and autistic traits were reported in 6/8 pedigrees.
Table 1

Clinical and genetic characteristics of patients with SYN1-related disorders in literature and the study

ReferencesGarcia et al. [4]Nguyen et al. [11]Sirsi et al. [12]*Guarnieri et al. [16]Peron et al. [15]Darvish et al. [14]Ibarluzea et al. [13]Pedigree A (this study)Pedigree B (this study)
Country (ethnic)

England

(unknown)

Canada

(French-Canadian)

America

(Latino)

Italy

(unknown)

Italy

(unknown)

America

(unknown)

Spain

(unknown)

China

(Han)

China

(Han)

Basic information
Sex of probandsMale (assumed)MaleMaleUnknownMaleMaleMaleMaleMale
Affected family membersMale (10)

Male (10);

Female (2)

Male (8);

Female (2)

Male (2)Male (3)Male (2)Male (1)Male (1)
Carrier family membersFemale (9)Female (8)Female (1)Female (1)Female (1)UnknownFemale (5)Female (3)Female (1)
SYN1 variants

c.G1068A (p.W356X)

[NM_133399]

c.C1663T

(p.Q555X)

[NM_133399]

c.C1264T

(p.R422X)

[NM_133399]

c.C236G (p.S79W)

[NM_133399]

c.527 + 1G > T

[NM_133399]

c.G1259A

(p. R420Q)

[NM_133399]

c.G796A (p.V266M)

[NM_133399]

c.C1076A (p.T359K)

[NM_133399]

c.C1444T (p.Q482X)

[NM_133399]

DiagnosisVariable epilepsy, learning disabilities, and aggressive behaviorX-linked focal epilepsy with reflex related-bathing seizuresFocal epilepsy and reflex related- bathing seizures, autism, and intellectual disabilityNon-syndromic intellectual disabilityHot water-sensitive epilepsyAutism and progressive intellectual disability without epilepsyIntellectual disability and paranoid schizophreniaIntellectual disability and complex febrile seizuresEpilepsy, behavioral disorders and learning disabilities
Clinical features
Degree of intellectual disabilityNormal or mildNormal or mildModerate to severeNormal or mildID from early childhood mental regressionMildProfoundModerate
Presence of epilepsyYYYNYNNYY
Onset age of seizures6–27y1y8m–50yEarly childhood8y--1y7y
Seizure semiologyTonic–clonic, reflex, and partial and complex-partial seizuresSpontaneous complex partial seizures and reflex seizures triggered by bathingFocal seizures and reflex seizures triggered by bathingHot water sensitive seizures at the beginning, subsequently followed by nonreflex seizures--Tonic–clonic seizures triggered by feverTonic–clonic seizures
Seizure frequencyEpisodicEpisodic1–2 times per monthUnknown--Only 2 timesEpisodic
Seizure control or notYMost affected members have achieved seizure controlIntractable to AEDs, seizures reduce about 50% by VNSUnknownYY
Abnormal behavior
AggressionYNNNNNNY
Autistic traitsYYYNYYNN
EEG findingsSome evidence of spikes in the left temporal region or normalRhythmic theta activity over temporal head regionsSpikes on the left temporal regionBilateral rhythmic theta activity over the frontocentral and vertex regionsNormalOccasional sharp-waves occurring in bilateral frontal areas during sleep
Brian MRI imagingNormalHippocampal atrophyNormalMarked generalized frontal atrophyNormalNormal
Other findingsMacrocephalyNNNNSphincter dysfunctionNBilateral esotropiaAmetropia

AEDs anti-epileptic drugs, EEG electroencephalography, ID intellectual disability, MRI magnetic resonance imaging, m month, N no, Y yes, y year, VNS vagal nerve stimulator

*The pedigree in the study has a maternal family history of epilepsy but lacks familial genetic results due to financial reasons

Clinical and genetic characteristics of patients with SYN1-related disorders in literature and the study England (unknown) Canada (French-Canadian) America (Latino) Italy (unknown) Italy (unknown) America (unknown) Spain (unknown) China (Han) China (Han) Male (10); Female (2) Male (8); Female (2) c.G1068A (p.W356X) [NM_133399] c.C1663T (p.Q555X) [NM_133399] c.C1264T (p.R422X) [NM_133399] c.C236G (p.S79W) [NM_133399] c.527 + 1G > T [NM_133399] c.G1259A (p. R420Q) [NM_133399] c.G796A (p.V266M) [NM_133399] c.C1076A (p.T359K) [NM_133399] c.C1444T (p.Q482X) [NM_133399] AEDs anti-epileptic drugs, EEG electroencephalography, ID intellectual disability, MRI magnetic resonance imaging, m month, N no, Y yes, y year, VNS vagal nerve stimulator *The pedigree in the study has a maternal family history of epilepsy but lacks familial genetic results due to financial reasons

Discussion

SYN1 is the only member of the synapsin gene family that is confirmed as pathogenic cause of human monogenic disease until now. Notably, all significant SYN1 variants in literature and our research were confirmed to be inherited from the maternal side, supporting a characteristic of familial clustering in the disease. Therefore, detailed family history inquiries would help clinical diagnosis. Interestingly, none of identified causative SYN1 variants located in domain A and E or F of the encoded protein. But some SYN1 variants in these domains were recorded in the gnomAD database with low-rate frequency [8]. Domain A is highly conserved in diverse synapsin subtypes and species [2], and domain E or F play functions in forming SV reserve pool, regulating kinetics of exocytosis, and SV cycling [2, 19]. We speculated that defects in the middle motifs of Synapsin I, including domain B, C and D, are inclined to lead to neurodevelopmental disorders in human after birth, while the possible harmfulness of variants in the other domains remain unknown. Here, we firstly reported two male patients with SYN1-related neurodevelopmental disorder in Asian population, which added clinical evidence for the condition. Although proband A had more impaired cognition than most cases in the disease, Darvish et al. also identified three male patients with progressive intellectual disabilities in an American family with significant SYN1 variant [14]. Patient A had an uncertain significance SYN1 variant (c.C1076A, p.T359K), which was not present in his healthy brother, and the Trios-WES showed no other possible pathogenic variants. Therefore, in the present situation, we considered the variant could explain proband A’s clinical symptoms, functional studies might help us make decisions in future research. Moreover, proband A was more in line with the diagnosis of X-linked intellectual disability. For proband B, he had a pathogenic SYN1 variant. He showed mild cognition impairment, learning disabilities and behavior problems, which was a typical case of X-linked epilepsy with variable learning disabilities and behavior disorders. In the other hand, the phenotypes of the disease differ in genders and individuals. Overall, we noticed that females are less susceptible than males, and only few female carriers present mild cognition impairment and febrile seizures, which might attribute to X-chromosome random inactivation (XCI) [10, 16]. And probands in previous reported pedigrees often are male, suggesting that female patients are prone to be neglected. In our study, only male patients had clinical manifestations, while female obligate carriers had no neurological signs. It is worth noting that these phenotypic differences of this disease also exist in different individuals of the same sex in the same pedigree. In an England four generation family, 10 male patients were identified. Some of them only had epilepsy, while others also had learning difficulties, macrocephaly, and aggressive behavior [4]. The phenotypic differences among different individuals in the disorder may be due to the complementary mechanism of synaptic protein functions in the body, which needs further research. Hence, we reached an conclusion that SYN1-related disorder is a neurodevelopmental disorder with high clinical heterogeneity. However, we still could conclude three main clinical manifestations of the condition after systematic reviewing previous reported cases with SYN1-related disorder. Firstly, patients had variable degrees of intellectual disabilities. As was described in the result section, normal or mild cognition impairments were more common in these pedigrees. The reflex seizure related to bathing or showering, was another remarkable clinical manifestation in the disorder [11, 15]. Our cases had no history of reflex seizure, but proband A was diagnosed as febrile seizures. Their seizures often responded well to antiepileptic drugs. Behavioral problems such as aggression, hyperactivity, and autistic traits were the third typical clinical features of SYN1-related disorders. Proband B in the research had apparent aggressive behaviors and attention-deficit, even though his behavioral assessment scales were negative. Patients with the above three significant clinical symptoms need to be alert to the possibility of SYN1-related neurodevelopmental disorder. Moreover, we also noticed that our two cases have eye problems including ametropia and strabismus, which has not been mentioned in other studies. According to the Human protein atlas database, SYN1 is expressed in human eye tissue at RNA level, nevertheless, there is no further evidence to support involvement of the protein in eye development [20]. Eye disorder might be a new clue for clinicians to identify the condition, however, it needs more data. Several functional analyses have been done in recent studies to elucidate the possible pathogenesis mechanisms in SYN1-related disorder [1, 14, 16]. Compared to human SYN1 wildtype, expression of human SYN1 variants such as S79W, A550T, T567A in SYN1 knockout (KO) mouse neurons failed to rescue neuron cell size and SV pools trafficking, and resulted in defective nerve terminal function [1, 16]. Variant R420Q could significantly disrupted neurite outgrowth and development in mouse primary hippocampal neurons [14]. These findings implicate that SYN1 variants detected in neurodevelopmental disorders lead to loss-of-function of the Synapsin-I protein in the brain network, and patients with the disease might benefit from improved protein function.

Conclusion

In conclusion, this is the first study about SYN1-related neurodevelopmental disorder in Asian population, which expands the genetic spectrum of the disease. Remarkably, all reported significant SYN1 variants were maternally inherited, and located in middle domains of the gene. Gender differences and phenotype variances should be considered in the disorder. Besides mental deficiency, reflex seizures and behavior problems, eye disorders might be helpful to identify the condition. Combining with previous studies, loss-of-function of Synapsin-I protein is the possible mechanism in patients with the disorder.
  16 in total

1.  The highly conserved synapsin domain E mediates synapsin dimerization and phospholipid vesicle clustering.

Authors:  Ilaria Monaldi; Massimo Vassalli; Angela Bachi; Silvia Giovedì; Enrico Millo; Flavia Valtorta; Roberto Raiteri; Fabio Benfenati; Anna Fassio
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

2.  Hot water epilepsy and SYN1 variants.

Authors:  Angela Peron; Nissan V Baratang; Maria Paola Canevini; Philippe M Campeau; Aglaia Vignoli
Journal:  Epilepsia       Date:  2018-11       Impact factor: 5.864

3.  SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function.

Authors:  Anna Fassio; Lysanne Patry; Sonia Congia; Franco Onofri; Amelie Piton; Julie Gauthier; Davide Pozzi; Mirko Messa; Enrico Defranchi; Manuela Fadda; Anna Corradi; Pietro Baldelli; Line Lapointe; Judith St-Onge; Caroline Meloche; Laurent Mottron; Flavia Valtorta; Dang Khoa Nguyen; Guy A Rouleau; Fabio Benfenati; Patrick Cossette
Journal:  Hum Mol Genet       Date:  2011-03-25       Impact factor: 6.150

4.  Novel West syndrome candidate genes in a Chinese cohort.

Authors:  Jing Peng; Ying Wang; Fang He; Chen Chen; Li-Wen Wu; Li-Fen Yang; Yu-Ping Ma; Wen Zhang; Zi-Qing Shi; Chao Chen; Kun Xia; Hui Guo; Fei Yin; Nan Pang
Journal:  CNS Neurosci Ther       Date:  2018-04-17       Impact factor: 5.243

5.  X-linked focal epilepsy with reflex bathing seizures: Characterization of a distinct epileptic syndrome.

Authors:  Dang Khoa Nguyen; Isabelle Rouleau; Geneviève Sénéchal; Ana Inés Ansaldo; Micheline Gravel; Fabio Benfenati; Patrick Cossette
Journal:  Epilepsia       Date:  2015-06-19       Impact factor: 5.864

6.  Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel.

Authors:  Kameryn M Butler; Cristina da Silva; John J Alexander; Madhuri Hegde; Andrew Escayg
Journal:  Pediatr Neurol       Date:  2017-09-06       Impact factor: 3.372

7.  A novel SYN1 missense mutation in non-syndromic X-linked intellectual disability affects synaptic vesicle life cycle, clustering and mobility.

Authors:  Fabrizia C Guarnieri; Davide Pozzi; Andrea Raimondi; Riccardo Fesce; Maria M Valente; Vincenza S Delvecchio; Hilde Van Esch; Michela Matteoli; Fabio Benfenati; Patrizia D'Adamo; Flavia Valtorta
Journal:  Hum Mol Genet       Date:  2017-12-01       Impact factor: 6.150

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients.

Authors:  Ana Fernández-Marmiesse; Iria Roca; Felícitas Díaz-Flores; Verónica Cantarín; Mª Socorro Pérez-Poyato; Ana Fontalba; Francisco Laranjeira; Sofia Quintans; Oana Moldovan; Blanca Felgueroso; Montserrat Rodríguez-Pedreira; Rogelio Simón; Ana Camacho; Pilar Quijada; Salvador Ibanez-Mico; Mª Rosario Domingno; Carmen Benito; Rocío Calvo; Antonia Pérez-Cejas; Mª Llanos Carrasco; Feliciano Ramos; Mª Luz Couce; Mª Luz Ruiz-Falcó; Luis Gutierrez-Solana; Margarita Martínez-Atienza
Journal:  Front Neurosci       Date:  2019-11-08       Impact factor: 4.677

10.  Phenotypic and genotypic characterization of families with complex intellectual disability identified pathogenic genetic variations in known and novel disease genes.

Authors:  Hossein Darvish; Luis J Azcona; Abbas Tafakhori; Roxana Mesias; Azadeh Ahmadifard; Elena Sanchez; Arman Habibi; Elham Alehabib; Amir Hossein Johari; Babak Emamalizadeh; Faezeh Jamali; Marjan Chapi; Javad Jamshidi; Yuji Kajiwara; Coro Paisán-Ruiz
Journal:  Sci Rep       Date:  2020-01-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.